CLINICAL LABORATORY TEST FINDINGS IN PATIENTS WITH CHRONIC FATIGUE SYNDROME

Citation
Dw. Bates et al., CLINICAL LABORATORY TEST FINDINGS IN PATIENTS WITH CHRONIC FATIGUE SYNDROME, Archives of internal medicine, 155(1), 1995, pp. 97-103
Citations number
31
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00039926
Volume
155
Issue
1
Year of publication
1995
Pages
97 - 103
Database
ISI
SICI code
0003-9926(1995)155:1<97:CLTFIP>2.0.ZU;2-K
Abstract
Background: Results of readily available clinical laboratory tests in patients with chronic fatigue syndrome were compared with results in h ealthy control subjects. Methods: Cases consisted of all 579 patients who met either the Centers for Disease Control and Prevention, Atlanta , Ga, British, or Australian case definition for chronic fatigue syndr ome. They were from chronic fatigue clinics in Boston, Mass, and Seatt le, Wash. Control subjects consisted of 147 blood donors who denied ch ronic fatigue. Outcome measures were the results of 18 clinical labora tory tests. Results: Age- and sex-adjusted odds ratios of abnormal res ults, comparing cases with control subjects, were as follows: circulat ing immune complexes, 26.5 (95% confidence interval [CI], 3.4-206); at ypical lymphocytosis, 11.4 (95% CI, 1.4-94); elevated immunoglobulin G , 8.5 (95% CI, 2.0-37); elevated alkaline phosphatase, 4.2 (95% CI, 1. 6-11); elevated total cholesterol, 2.1 (95% CI, 1.2-3.4); and elevated lactic dehydrogenase, 0.30 (95% CI, 0.16-0.56). Also, antinuclear ant ibodies were detected in 15% of cases vs 0% in the control subjects. T he results of these tests were generally comparable for the cases from Seattle and Boston. Although these tests served to discriminate the p opulation of patients from healthy control subjects, at the individual level they were not as useful. Conclusions: Patients with chronic fat igue syndrome who were located in two geographically distant areas had abnormalities in the results of several readily available clinical la boratory tests compared with healthy control subjects. The immunologic abnormalities are in accord with a growing body of evidence suggestin g chronic, low-level activation of the immune system in chronic fatigu e syndrome. While each of these laboratory findings supports the diagn osis of chronic fatigue syndrome, each lacks sufficient sensitivity to be a diagnostic test. Furthermore, the specificity of these findings relative to other organic and psychiatric conditions that can produce fatigue remains to be established.